✨ Medicines Approval Notices




21 OCTOBER 2010 NEW ZEALAND GAZETTE, No. 143

Product: Cefuroxime-AFT
Active Ingredient: Cefuroxime sodium 826mg equivalent to 750mg cefuroxime
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Limassol, Cyprus

Product: Cefuroxime-AFT
Active Ingredient: Cefuroxime sodium 1652mg equivalent to 1500mg cefuroxime
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Limassol, Cyprus

Product: Cipflox
Active Ingredient: Ciprofloxacin 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Maco Productions SAS, Mouvaux, France

Product: Loperamide Relief
Active Ingredient: Loperamide hydrochloride 2mg
Dosage Form: Capsule
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Adcock Ingram Limited - A Medreich Group Company, Bangalore, India

Product: Nevirapine Alphapharm
Active Ingredient: Nevirapine 200mg
Dosage Form: Tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India

Product: Noraped
Active Ingredient: Noradrenaline acid tartrate monohydrate 8mg
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Haupt Pharma Livron, Livron sur Drome, France

Product: Onglyza
Active Ingredient: Saxagliptin 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: Bristol-Myers Squibb Company, Indiana, United States of America

Product: Pravastatin
Active Ingredient: Pravastatin sodium 10mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India

Product: Pravastatin
Active Ingredient: Pravastatin sodium 20mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India

Product: Pravastatin
Active Ingredient: Pravastatin sodium 40mg
Dosage Form: Tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India

Product: Rizamelt
Active Ingredient: Rizatriptan benzoate 7.265mg equivalent to rizatriptan 5mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India

3579



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 143





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines, Consent, Distribution, Health

πŸ₯ Approval of Cefuroxime-AFT (750mg)

πŸ₯ Health & Social Welfare
Medicine, Cefuroxime, AFT Pharmaceuticals, Injection

πŸ₯ Approval of Cefuroxime-AFT (1500mg)

πŸ₯ Health & Social Welfare
Medicine, Cefuroxime, AFT Pharmaceuticals, Injection

πŸ₯ Approval of Cipflox

πŸ₯ Health & Social Welfare
Medicine, Ciprofloxacin, Mylan, Infusion

πŸ₯ Approval of Loperamide Relief

πŸ₯ Health & Social Welfare
Medicine, Loperamide, Mylan, Capsule

πŸ₯ Approval of Nevirapine Alphapharm

πŸ₯ Health & Social Welfare
Medicine, Nevirapine, Mylan, Tablet

πŸ₯ Approval of Noraped

πŸ₯ Health & Social Welfare
Medicine, Noradrenaline, Mylan, Infusion

πŸ₯ Approval of Onglyza

πŸ₯ Health & Social Welfare
Medicine, Saxagliptin, AstraZeneca, Tablet

πŸ₯ Approval of Pravastatin (10mg)

πŸ₯ Health & Social Welfare
Medicine, Pravastatin, REX Medical, Tablet

πŸ₯ Approval of Pravastatin (20mg)

πŸ₯ Health & Social Welfare
Medicine, Pravastatin, REX Medical, Tablet

πŸ₯ Approval of Pravastatin (40mg)

πŸ₯ Health & Social Welfare
Medicine, Pravastatin, REX Medical, Tablet

πŸ₯ Approval of Rizamelt

πŸ₯ Health & Social Welfare
Medicine, Rizatriptan, Mylan, Orodispersible